Pain Intensity and Pain Relief
pain
Overall, pain intensity decreased from baseline (before study treatment initiation) until day 5 in the two study groups. Compared to the control group, significantly higher pain intensity reduction was observed in the Endocare group from the baseline up to day 3 (maximum on day 2 of 51.6% reduction in the Endocare group vs 21.2% in the control group). Concomitantly, a significant increase in pain relief was declared by the patients exposed to Endocare on days 1 and 2 compared to those using the digital sham control device. In contrast to usual pain medications, there are no particular safety risks associated with repeated use of a VR solution as confirmed in this trial.These results confirmed the previously observed analgesic effects of the self-administered Endocare treatment (maximum pain intensity reduction of 42%) [